Keith Kendall

Keith Kendall

Net worth: 3 M $ as of 2024-03-30

66 year
Health Technology
Consumer Services
Electronic Technology

Profile

Keith J.
Kendall
served as President, Chief Executive Officer & Director at Aquestive Therapeutics, Inc. from 2014 to 2022.
Prior to that, he was Vice President & Managing Director at Hewlett-Packard Financial Services Co. from 1999 to 2006.
He also served as Non-Executive Director at Biodexa Pharmaceuticals Plc from 2010 to 2014.
Before his time at Hewlett-Packard, he was President at CIT Communications Finance Corp.
and NCR Credit Corp.
from 1985 to 1998.
Kendall holds an MBA from Pace University and an undergraduate degree from St. John's University.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
2023-03-14 637,149 ( 0.71% ) 3 M $ 2024-03-30

Former positions of Keith Kendall

CompaniesPositionEnd
FEMASYS INC. Director/Board Member 2023-11-07
AQUESTIVE THERAPEUTICS, INC. Chief Executive Officer 2022-05-16
BIODEXA PHARMACEUTICALS PLC Director/Board Member 2014-11-30
Corporate Officer/Principal 2006-05-31
President -
See the detail of Keith Kendall's experience

Training of Keith Kendall

Pace University Masters Business Admin
St. John's University Undergraduate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Keith Kendall's experience

Connections

40

1st degree connections

8

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies3
FEMASYS INC.

Electronic Technology

AQUESTIVE THERAPEUTICS, INC.

Health Technology

BIODEXA PHARMACEUTICALS PLC

Health Technology

Private companies3

Commercial Services

Finance

NCR Credit Corp.

See company connections